Explore GSK
Core profile pages, annual revenue records, and related research hubs for this company.
Explore GSK
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
GBP 32.7B
Market Cap
$101.0B
Net Income
$5.7B
Employees
66,800
GSK's FY2025 results show the post-Haleon biopharma model in cleaner form: turnover reached GBP 32.667 billion, up 4% at actual exchange rates and 7% at constant exchange rates, while profit attributable to shareholders rose to GBP 5.716 billion. Specialty Medicines generated GBP 13.5 billion, Vaccines GBP 9.2 billion, and General Medicines GBP 10.0 billion, giving the company a broad but still therapeutically concentrated portfolio. The financial story is no longer about a consumer-health conglomerate. Since the 2022 Haleon demerger, GSK has used a more focused capital allocation model around HIV, respiratory, immunology and inflammation, oncology, infectious disease, and vaccine platforms. Luke Miels' move into the CEO role on January 1, 2026 keeps that strategy tied to commercial execution, pipeline productivity, and the durability of high-value franchises as older HIV and respiratory products face patent and pricing pressure.
Revenue Trend Analysis
YoY Change
+4.1%
2-Year CAGR
+3.8%
Peak Year
2025
Trend
Consistent Growth
GSK plc has reported revenue across 3 fiscal years, compounding at +3.8% annually over 2 years. The most recent year saw a 4.1% increase versus the prior year. Revenue peaked in 2025 at $32.7B. Out of 2 reported periods, 2 showed growth and 0 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $32.7B | $5.7B | +4.1% |
| FY2024 | $31.4B | — | +3.5% |
| FY2023 | $30.3B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
GSK reported about GBP 32.7B in FY2025 revenue. Use the financials page for multi-year trends.
Yes, with mix shifting toward vaccines and specialty margins post-demerger.
GSK employs about 66,800 people across operations and corporate functions.
The GSK financials page lists annual revenue history and segment context.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "GSK plc Revenue & Financials." CorpDigest, https://corpdigest.com/company/gsk/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>GSK plc reported $33B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/gsk/financials" target="_blank" rel="noopener">CorpDigest — GSK plc financials</a></div>